Search
Molecular Partners AG
MOLNAdd to Watchlist
4.300USD
+0.040+0.94%
Close 09-23 16:00（ET）
160.82MMarket Cap
LossP/E TTM
MOLN Financials
See Molecular Partners AG's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
160.82M
Dividend TTM
0.00
P/E TTM
-1.97
EPS TTM
-1.94
Revenue
0.00
Net Profit
-54.04M
ROE
-59.01%
ROA
-50.73%
Molecular Partners AG Earnings Date
Latest Release
Aug 25, 2026
EPS / Forecast
-0.44/-0.43
Revenue / Forecast
0.00/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What are the current assets of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its current assets were 122.44M, with a year-on-year change of -29.89.
What are the total assets of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its total assets of Molecular Partners AG were 129.05M, with a year-on-year change of -28.08.
What are the total liabilities of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its total liabilities of Molecular Partners AG were 27.52M, with a year-on-year change of 43.92.
What is the total equity of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its total equity of Molecular Partners AG was 101.53M, with a year-on-year change of -36.67.
What is the net operating income of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its net operating income of Molecular Partners AG was -70.06M, with a year-on-year change of -1.11.
What is the net investment of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its net investment of Molecular Partners AG was 89.51M, with a year-on-year change of 118.16.
What is the net financing of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its net financing of Molecular Partners AG was -1.45M, with a year-on-year change of -108.89.
What is the Earnings Per Share (EPS) of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its Earnings Per Share (EPS) was -2.09, with a year-on-year change of -19.27.
What is the net income of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its net income was -77.92M, with a year-on-year change of -27.37.
What is the debt-to-asset ratio of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its debt-to-asset ratio was 3.57, with a year-on-year change of 131.49.
What is the Return on Equity (ROE) of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its Return on Equity (ROE) was -55.55, with a year-on-year change of -63.46.
What is the Return on Assets (ROA) of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its Return on Assets (ROA) was -47.31, with a year-on-year change of -56.20.
What is the operating profit of Molecular Partners AG?
According to Molecular Partners AG's FY2025 earnings report, its operating profit was -70.06M, with a year-on-year change of -1.11.